应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
09989 海普瑞
休市中 07-03 16:08:13
4.140
+0.000
0.00%
最高
4.240
最低
4.110
成交量
41.75万
今开
4.170
昨收
4.140
日振幅
3.14%
总市值
60.73亿
流通市值
9.11亿
总股本
14.67亿
成交额
173.48万
换手率
0.19%
流通股本
2.20亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
股东洪泽君增持海普瑞(09989)32.85万股 每股作价约3.99港元
智通财经网 · 07-02 18:59
股东洪泽君增持海普瑞(09989)32.85万股 每股作价约3.99港元
智通AH统计|6月30日
智通财经 · 06-30
智通AH统计|6月30日
海普瑞涨超3%
每日经济新闻 · 06-23
海普瑞涨超3%
港股异动 | 海普瑞(09989)涨超3% 近日旗下依诺肝素钠注射液在肯尼亚获批
智通财经 · 06-23
港股异动 | 海普瑞(09989)涨超3% 近日旗下依诺肝素钠注射液在肯尼亚获批
海普瑞5月无新增发行或股份变动
公告速递 · 06-02
海普瑞5月无新增发行或股份变动
海普瑞更新末期股息派发日,每股派0.145元
公告速递 · 05-26
海普瑞更新末期股息派发日,每股派0.145元
海普瑞(09989)将于6月18日派发末期股息每10股1.6604港元
智通财经 · 05-26
海普瑞(09989)将于6月18日派发末期股息每10股1.6604港元
海普瑞将于7月22日派发末期股息每10股1.6604港元
新浪港股 · 05-24
海普瑞将于7月22日派发末期股息每10股1.6604港元
海普瑞(002399)披露董事会完成换届选举及聘任高级管理人员、证券事务代表的公告,5月22日股价下跌0.1%
证券之星 · 05-22
海普瑞(002399)披露董事会完成换届选举及聘任高级管理人员、证券事务代表的公告,5月22日股价下跌0.1%
海普瑞宣派末期股息每10股1.45元人民币,更新汇率及代扣所得税安排
公告速递 · 05-22
海普瑞宣派末期股息每10股1.45元人民币,更新汇率及代扣所得税安排
海普瑞(09989)将于7月22日派发末期股息每10股1.6604港元
智通财经 · 05-22
海普瑞(09989)将于7月22日派发末期股息每10股1.6604港元
海普瑞宣派末期股息每股0.16604港元,派息日7月22日
公告速递 · 05-22
海普瑞宣派末期股息每股0.16604港元,派息日7月22日
海普瑞(09989):王建一获选为职工代表董事
智通财经 · 05-22
海普瑞(09989):王建一获选为职工代表董事
海普瑞完成换届选举:李锂当选董事长 单宇任总经理
财中社 · 05-22
海普瑞完成换届选举:李锂当选董事长 单宇任总经理
智通AH统计|5月14日
智通财经 · 05-14
智通AH统计|5月14日
海普瑞4月股份变动月报表,股本维持稳定
公告速递 · 05-06
海普瑞4月股份变动月报表,股本维持稳定
每周股票复盘:海普瑞(002399)Q1净利增19.79%
证券之星 · 05-03
每周股票复盘:海普瑞(002399)Q1净利增19.79%
海普瑞(002399)2026年一季报简析:净利润同比增长19.79%,三费占比上升明显
证券之星 · 05-01
海普瑞(002399)2026年一季报简析:净利润同比增长19.79%,三费占比上升明显
海普瑞(002399)披露2026年第一季度报告,4月29日股价下跌0.09%
证券之星 · 04-29
海普瑞(002399)披露2026年第一季度报告,4月29日股价下跌0.09%
海普瑞2025年营收稳增至54.38亿元 肝素与CDMO双主业协同发力
公告速递 · 04-29
海普瑞2025年营收稳增至54.38亿元 肝素与CDMO双主业协同发力
加载更多
公司概况
公司名称:
海普瑞
所属市场:
SEHK
上市日期:
--
主营业务:
深圳市海普瑞药业集团股份有限公司是一家主要从事肝素产业链、生物大分子合同开发和生产组织(CDMO)和创新药物的投资、开发及商业化的中国公司。该公司运营四个分部。药品制剂分部生产和销售依诺肝素钠注射液等。原料药物分部生产和销售标准肝素活性药物和依诺肝素活性药物等。CDMO分部提供药物的中间体和原料药工艺研发服务,包括工艺研究、优化、分析检测、制剂研究等。其他分部从事其他产品业务,如胰酶、肠衣等。该公司在中国国内和海外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"09989","market":"HK","secType":"STK","nameCN":"海普瑞","latestPrice":4.14,"timestamp":1783066093500,"preClose":4.14,"halted":0,"volume":417500,"delay":0,"changeRate":0,"floatShares":220094500,"shares":1467000000,"eps":0.2753945165718768,"marketStatus":"休市中","change":0,"latestTime":"07-03 16:08:13","open":4.17,"high":4.24,"low":4.11,"amount":1734835,"amplitude":0.031401,"askPrice":4.18,"askSize":18500,"bidPrice":4.14,"bidSize":4000,"shortable":0,"etf":0,"ttmEps":0.29980080643263385,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1783301400000},"marketStatusCode":7,"adr":0,"listingDate":1594137600000,"exchange":"SEHK","adjPreClose":4.14,"dividendRate":0.040097,"openAndCloseTimeList":[[1783042200000,1783051200000],[1783054800000,1783065600000]],"volumeRatio":0.6071844094344646,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"002399","market":"SZ","secType":"STK","nameCN":"海普瑞","latestPrice":9.55,"timestamp":1783062000000,"preClose":9.4,"halted":0,"volume":6116700,"delay":0,"premium":"-62.50"}},"requestUrl":"/m/hq/s/09989","defaultTab":"news","newsList":[{"id":"2648502516","title":"股东洪泽君增持海普瑞(09989)32.85万股 每股作价约3.99港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2648502516","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648502516?lang=zh_cn&edition=full","pubTime":"2026-07-02 18:59","pubTimestamp":1782989980,"startTime":"0","endTime":"0","summary":"6月30日,股东洪泽君增持海普瑞(09989)32.85万股,每股作价3.986港元,总金额约为130.94万港元。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20260702/20260702190218_76310.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260702/20260702190218_76310.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1462474.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0070","EWH","BK0188","BK0239","BK1191","09989","002399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647535683","title":"智通AH统计|6月30日","url":"https://stock-news.laohu8.com/highlight/detail?id=2647535683","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647535683?lang=zh_cn&edition=full","pubTime":"2026-06-30 16:15","pubTimestamp":1782807306,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,截止6月30日收盘,东北电气、浙江世宝、安德利果汁分列AH溢价率前三位,溢价率分别为864.29%、377.31%、360.00%;宁德时代、兆易创新、招商银行分列AH溢价率末三位,溢价率分别为-32.94%、-16.32%、-5.34%。其中东北电气、安德利果汁、龙蟠科技的偏离值位居前三,分别为136.07%、77.52%、56.51%;另外,弘业期货、新天绿色能源、秦港股份的偏离值位居后三,分别为-30.84%、-24.60%、-16.67%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1461093.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00719","LU0823426480.USD","02865","159982","00991","00916","LU2045819591.USD","03296","01088","02899","02465","02338","LU0737861772.HKD","SG9999006597.SGD","03678","BK1151","01349","01138","03143","01108","02359","03750","02701","03369","00588","03986","02208","00300","01033","03200","09989","02691","00390","LU0359202008.SGD","06031","00042","LU0359201612.USD","01057","06936","399300","LU0049853897.USD","01081","00956","03968","EWH","01276","LU2242644610.SGD","02218","00895"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645883271","title":"海普瑞涨超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645883271","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645883271?lang=zh_cn&edition=full","pubTime":"2026-06-23 14:51","pubTimestamp":1782197486,"startTime":"0","endTime":"0","summary":"6月23日,海普瑞(09989.HK)涨超3%,早盘一度涨逾14%。截至发稿,涨2.6%,报3.95港元,成交额1475.14万港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606233779660254.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606233779660254.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["09989","BK1191","BK0239","BK0188","BK0070","002399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645916883","title":"港股异动 | 海普瑞(09989)涨超3% 近日旗下依诺肝素钠注射液在肯尼亚获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2645916883","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645916883?lang=zh_cn&edition=full","pubTime":"2026-06-23 14:40","pubTimestamp":1782196835,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,海普瑞涨超3%,早盘一度涨逾14%。消息面上,据海普瑞药业官微消息,近日,海普瑞药业宣布,集团全球制剂业务的核心承载主体、旗下全资子公司天道医药的依诺肝素钠注射液在肯尼亚获得批准。这是海普瑞旗下依诺肝素钠注射液在非洲获批的第四个国家,至此,该产品全球获批国家和地区数量增至80个。目前,海普瑞药业依托深圳市南山、坪山两大制剂生产基地,已形成年产5.5亿支依诺肝素钠注射液的世界级规模化产能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1457407.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0188","VXUS","BK0239","BK0070","BK4588","002399","BK4585","BK1191","09989"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182990395","title":"海普瑞5月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1182990395","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182990395?lang=zh_cn&edition=full","pubTime":"2026-06-02 16:37","pubTimestamp":1780389468,"startTime":"0","endTime":"0","summary":"深圳市海普瑞药业集团股份有限公司2026年5月股份变动月报表显示,截至2026年5月31日,公司股本整体暂未发生变动。本次公告于2026年6月2日发布。当月公司未进行新增发行、购回、注销或库藏股操作,亦无股权激励计划及可转债、购股权或其他证券类变动。海普瑞在月报中表示,公司已就本月所有涉及证券发行或库藏股转让获得董事会正式批准,并遵守香港联交所《上市规则》及法律法规各项规定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09989"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105783618","title":"海普瑞更新末期股息派发日,每股派0.145元","url":"https://stock-news.laohu8.com/highlight/detail?id=1105783618","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1105783618?lang=zh_cn&edition=full","pubTime":"2026-05-26 16:37","pubTimestamp":1779784637,"startTime":"0","endTime":"0","summary":"海普瑞发布更新公告,明确2025年度末期股息的派发日期调整为2026年6月18日。此前公司已宣派每股0.145元人民币的末期股息,该方案已于2026年5月22日获股东批准。根据公告,默认派发货币为港元,每10股派发1.6604港元,汇率折算为1元人民币兑1.1451港元。除净日为2026年5月27日,股东欲获得股息分派须于2026年5月28日16:30前递交股份过户文件。公司将于2026年5月29日至6月2日暂停办理股份过户登记,股权登记日为2026年6月2日。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"海普瑞更新末期股息派发日,每股派0.145元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09989"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638592398","title":"海普瑞(09989)将于6月18日派发末期股息每10股1.6604港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2638592398","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638592398?lang=zh_cn&edition=full","pubTime":"2026-05-26 16:32","pubTimestamp":1779784346,"startTime":"0","endTime":"0","summary":"智通财经APP讯,海普瑞(09989)发布公告,将于2026年6月18日派发截至2025年12月31日止年度的末期股息每10股1.6604港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445962.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VIG","BK0239","EWH","002399","BK4588","BK0188","BK4585","BK1191","09989","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637130308","title":"海普瑞将于7月22日派发末期股息每10股1.6604港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2637130308","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637130308?lang=zh_cn&edition=full","pubTime":"2026-05-24 16:54","pubTimestamp":1779612840,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 海普瑞(09989)发布公告,将于2026年7月22日派发截至2025年12月31日止年度的末期股息每10股1.6604港元。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:卢昱君","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-05-24/doc-inhyytnk3405613.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4585","09989","BK0188","BK4588","BK0070","BK0239","BK1191","EWH","VIG","002399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637334860","title":"海普瑞(002399)披露董事会完成换届选举及聘任高级管理人员、证券事务代表的公告,5月22日股价下跌0.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637334860","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637334860?lang=zh_cn&edition=full","pubTime":"2026-05-22 22:39","pubTimestamp":1779460755,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘,海普瑞报收于10.19元,较前一交易日下跌0.1%,最新总市值为149.52亿元。公告显示,公司于2026年5月22日召开2025年度股东会及第七届董事会第一次会议,完成董事会换届选举,并聘任高级管理人员及证券事务代表。同时选举产生董事会各专门委员会成员。公司聘任单宇为总经理,李坦为副总经理,陈娟为财务负责人,钱风奇为董事会秘书,张文为证券事务代表。相关人员均已取得相应资格证书,具备任职资格。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200045442.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","002399","BK0188","09989","BK1191","BK0070","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156560392","title":"海普瑞宣派末期股息每10股1.45元人民币,更新汇率及代扣所得税安排","url":"https://stock-news.laohu8.com/highlight/detail?id=1156560392","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156560392?lang=zh_cn&edition=full","pubTime":"2026-05-22 21:26","pubTimestamp":1779456393,"startTime":"0","endTime":"0","summary":"海普瑞发布更新公告,就截至2025年12月31日止年度的末期股息公布派息细节。公司已于2026年5月22日举行的股东周年大会上批准派发末期股息,金额为每10股1.45元人民币。公司预设派发货币为港元,按1人民币兑1.1451港元的汇率折算,折合每10股派发1.6604港元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"海普瑞宣派末期股息每10股1.45元人民币,更新汇率及代扣所得税安排","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09989"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637312478","title":"海普瑞(09989)将于7月22日派发末期股息每10股1.6604港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2637312478","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637312478?lang=zh_cn&edition=full","pubTime":"2026-05-22 21:22","pubTimestamp":1779456151,"startTime":"0","endTime":"0","summary":"智通财经APP讯,海普瑞(09989)发布公告,将于2026年7月22日派发截至2025年12月31日止年度的末期股息每10股1.6604港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445308.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09989","BK0239","BK0188","EWH","BK4588","VIG","002399","BK1191","BK4585","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176162973","title":"海普瑞宣派末期股息每股0.16604港元,派息日7月22日","url":"https://stock-news.laohu8.com/highlight/detail?id=1176162973","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176162973?lang=zh_cn&edition=full","pubTime":"2026-05-22 21:03","pubTimestamp":1779455005,"startTime":"0","endTime":"0","summary":"海普瑞在2025年年度股东大会上通过利润分配预案,将向股东派发截至2025年12月31日止年度的末期股息。H股股东每股获派0.16604港元,A股股东则以人民币支付。为厘定收取股息资格,公司H股股东名册将于2026年5月29日至6月2日暂停办理股份过户登记,H股股东最迟须于2026年5月28日下午四时三十分前递交过户文件。股息支票预计于2026年7月22日前后寄发。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"海普瑞宣派末期股息每股0.16604港元,派息日7月22日","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09989"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637141213","title":"海普瑞(09989):王建一获选为职工代表董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2637141213","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637141213?lang=zh_cn&edition=full","pubTime":"2026-05-22 20:54","pubTimestamp":1779454461,"startTime":"0","endTime":"0","summary":"智通财经APP讯,海普瑞(09989)发布公告,王建一先生已获选为第七届董事会职工代表董事;及张平先生于任期届满后,不再担任第六届董事会职工代表董事,均自2025年年度股东大会结束起生效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445280.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0070","002399","BK0239","09989","BK0188","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637314472","title":"海普瑞完成换届选举:李锂当选董事长 单宇任总经理","url":"https://stock-news.laohu8.com/highlight/detail?id=2637314472","media":"财中社","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637314472?lang=zh_cn&edition=full","pubTime":"2026-05-22 20:39","pubTimestamp":1779453540,"startTime":"0","endTime":"0","summary":"5月22日,海普瑞(002399/09989)发布公告,公司召开2025年度股东会,审议通过了第七届董事会的选举,包括3名非独立董事和3名独立董事。新董事会成员包括非独立董事李锂(董事长)、李坦、单宇,独立董事黄鹏、易铭、浦洪,以及职工董事王建一。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605223746998745.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0239","BK1191","BK0188","BK0070","002399","09989"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635794944","title":"智通AH统计|5月14日","url":"https://stock-news.laohu8.com/highlight/detail?id=2635794944","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635794944?lang=zh_cn&edition=full","pubTime":"2026-05-14 16:15","pubTimestamp":1778746506,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,截止5月14日收盘,东北电气、浙江世宝、弘业期货分列AH溢价率前三位,溢价率分别为575.00%、366.67%、313.94%;宁德时代、兆易创新、招商银行分列AH溢价率末三位,溢价率分别为-25.44%、-17.12%、-4.61%。其中大唐发电、南华期货股份、安德利果汁的偏离值位居前三,分别为128.05%、57.70%、54.74%;另外,龙旗科技、中国人寿、中国交通建设的偏离值位居后三,分别为-18.16%、-16.21%、-15.00%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1441686.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01276","03143","00811","399300","03296","00991","09981","00187","00568","02628","EWH","01812","06127","LU0543330483.HKD","601318","82318","PAImain","03996","00981","159982","02338","06166","00553","03678","02218","09989","01057","02899","01108","IE00BYV24P56.USD","03328","06826","00323","01349","03750","00300","02359","00042","PNGAY","02318","03986","HPAD.SI","03145","02691","09611","01033","LU0898667661.SGD","03968","01800"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119753418","title":"海普瑞4月股份变动月报表,股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1119753418","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119753418?lang=zh_cn&edition=full","pubTime":"2026-05-06 16:41","pubTimestamp":1778056905,"startTime":"0","endTime":"0","summary":"深圳市海普瑞药业集团股份有限公司(股票代码:09989,股票名称:海普瑞)于2026年5月6日公布了截至2026年4月30日止月份之股份变动月报表。公告显示,公司已发行H股220,094,500股,A股1,247,201,704股,注册股本为人民币1,467,296,204元,较上个月均无变动。\n公告指出,在2026年4月期间,公司未进行新的股份增发、购回或注销,也未发生库藏股相关变动;无任何股份期权、承诺发行权证、可转债或其他股本工具的新增、变更或失效。在本月末,公司总股本继续保持稳定。\n公司同时表示,已遵守香港联交所《上市规则》及相关法律法规,并由联席公司秘书钱风奇签署确认。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09989"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632086476","title":"每周股票复盘:海普瑞(002399)Q1净利增19.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632086476","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632086476?lang=zh_cn&edition=full","pubTime":"2026-05-03 08:18","pubTimestamp":1777767495,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘,海普瑞报收于10.87元,较上周的10.93元下跌0.55%。本周,海普瑞4月30日盘中最高价报11.04元。本周关注点业绩披露要点:海普瑞2026年一季报显示归母净利润1.88亿元,同比上升19.79%。业绩披露要点海普瑞2026年一季报显示,一季度公司主营收入13.31亿元,同比下降4.55%;归母净利润1.88亿元,同比上升19.79%;扣非净利润7149.39万元,同比下降62.15%;负债率28.12%,投资收益3033.14万元,财务费用1.28亿元,毛利率34.15%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300002052.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002399","BK0188","09989","BK1191","BK0070","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632660132","title":"海普瑞(002399)2026年一季报简析:净利润同比增长19.79%,三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2632660132","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632660132?lang=zh_cn&edition=full","pubTime":"2026-05-01 06:41","pubTimestamp":1777588863,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期海普瑞发布2026年一季报。截至本报告期末,公司营业总收入13.31亿元,同比下降4.55%,归母净利润1.88亿元,同比上升19.79%。本报告期海普瑞三费占比上升明显,财务费用、销售费用和管理费用总和占总营收同比增幅达162.25%。去年的净利率为6.25%,算上全部成本后,公司产品或服务的附加值一般。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050100006809.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09989","002399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631543515","title":"海普瑞(002399)披露2026年第一季度报告,4月29日股价下跌0.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631543515","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631543515?lang=zh_cn&edition=full","pubTime":"2026-04-29 22:24","pubTimestamp":1777472683,"startTime":"0","endTime":"0","summary":"截至2026年4月29日收盘,海普瑞报收于10.77元,较前一交易日下跌0.09%,最新总市值为158.03亿元。该股当日开盘10.82元,最高10.94元,最低10.72元,成交额达4604.83万元,换手率为0.34%。近日,深圳市海普瑞药业集团股份有限公司召开第六届董事会第二十一次会议,审议通过《2026年第一季度报告》《2026年第一季度业绩公告》(H股)及《2025年度环境、社会和管治报告》。会议应参与表决董事7人,实际参与表决7人,表决结果均为7票同意、0票反对、0票弃权。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900069206.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09989","BK0188","BK0239","002399","BK1191","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195252676","title":"海普瑞2025年营收稳增至54.38亿元 肝素与CDMO双主业协同发力","url":"https://stock-news.laohu8.com/highlight/detail?id=1195252676","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195252676?lang=zh_cn&edition=full","pubTime":"2026-04-29 17:55","pubTimestamp":1777456530,"startTime":"0","endTime":"0","summary":"2025年度,海普瑞在主营肝素制剂与CDMO两大板块的协同带动下维持营收增长,实现营业收入54.38亿元人民币,同比上升3.4%。不过,受成本以及上年一次性收益基数等因素影响,年内盈利出现显著回落,归属于公司股东的净利润为3.49亿元人民币,相较2024年的6.47亿元人民币下降46%,反映出公司在成本端与市场环境中面临一定压力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"海普瑞2025年营收稳增至54.38亿元 肝素与CDMO双主业协同发力","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09989"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0809},{"period":"1month","weight":0.0073},{"period":"3month","weight":-0.1534},{"period":"6month","weight":-0.1665},{"period":"1year","weight":-0.2078},{"period":"ytd","weight":-0.1745}],"compareEarnings":[{"period":"1week","weight":0.0299},{"period":"1month","weight":-0.0891},{"period":"3month","weight":-0.0703},{"period":"6month","weight":-0.1135},{"period":"1year","weight":-0.0299},{"period":"ytd","weight":-0.089}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"深圳市海普瑞药业集团股份有限公司是一家主要从事肝素产业链、生物大分子合同开发和生产组织(CDMO)和创新药物的投资、开发及商业化的中国公司。该公司运营四个分部。药品制剂分部生产和销售依诺肝素钠注射液等。原料药物分部生产和销售标准肝素活性药物和依诺肝素活性药物等。CDMO分部提供药物的中间体和原料药工艺研发服务,包括工艺研究、优化、分析检测、制剂研究等。其他分部从事其他产品业务,如胰酶、肠衣等。该公司在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.055012},{"month":2,"riseRate":0.5,"avgChangeRate":0.044203},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.066279},{"month":4,"riseRate":0.5,"avgChangeRate":0.026442},{"month":5,"riseRate":0.666667,"avgChangeRate":0.011756},{"month":6,"riseRate":0.333333,"avgChangeRate":0.009474},{"month":7,"riseRate":0.5,"avgChangeRate":0.020357},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.026021},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.052491},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.02807},{"month":11,"riseRate":0.166667,"avgChangeRate":-0.010172},{"month":12,"riseRate":0.166667,"avgChangeRate":-0.022578}],"exchange":"SEHK","name":"海普瑞","nameEN":"HEPALINK"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海普瑞(09989)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海普瑞(09989)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海普瑞,09989,海普瑞股票,海普瑞股票老虎,海普瑞股票老虎国际,海普瑞行情,海普瑞股票行情,海普瑞股价,海普瑞股市,海普瑞股票价格,海普瑞股票交易,海普瑞股票购买,海普瑞股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海普瑞(09989)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海普瑞(09989)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}